SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

YARW

Yarrow Bioscience, Inc.
NASDAQHealth Care

Latest close: 39.64 USD · Aug 26, 2026 · 1 year · split-adjusted

On the price, the facts of the public recordNo facts from the categories shown here in this window.
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 10, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 13, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year3
SEC filings on record64434 flagged findings
Reported transactions (Form 4)76since Dec 13, 2023 · and 20 other holdings
Corporate events (8-K)30since Jan 13, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as VYNE (until Jul 24, 26).

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-06-15share offering or dilution eventrecentOpen filing ↗
    “…through a combination of equity offerings, debt financings, collaborations, strategic alliances and licensing arrangements. On March…”
    +1 more passage from the same document
    • “…stock units (Note 13) ​ ​ ​ ​ 450,916 ​ ​ Shares available for grant under the Employee Share Purchase Plan (Note 13) ​ ​ ​ ​…”
  • 2026-06-15listing compliance noticerecentOpen filing ↗
    “…with the minimum bid price requirement. On March 11, 2026, VYNE received a letter (the “Extension Notice”) from Nasdaq notifying VYNE…”
    +1 more passage from the same document
    • “…additional 180 calendar days, or until September 7, 2026, to regain compliance with the minimum bid price requirement. Nasdaq’s…”
  • 2026-06-15capital return (buybacks/dividends)recentOpen filing ↗
    “…(each, a “Yarrow Pre-Funded Warrant”) will be converted into a pre-funded warrant to purchase shares of VYNE Common Stock on the…”
    +1 more passage from the same document
    • “…subject to adjustment as set forth in the Merger Agreement and the form of pre-funded warrant. If any shares of Yarrow Common Stock…”
  • 2026-06-15Department of Justice inquiryrecentOpen filing ↗
    “…and regulations requires the expenditure of substantial time and financial resources. Failure to comply with the applicable U.S.…”
    +1 more passage from the same document
    • “…Act of 1976 and (b) any notification or other document required to be filed in connection with the Merger under any…”
  • 2026-06-15merger or acquisition eventrecentOpen filing ↗
    “…424B3 TABLE OF CONTENTS Filed Pursuant to rule 424(b)(3) ​ Registration No 333-294804 ​ ​ ​ ​ ​ PROPOSED MERGER YOUR VOTE IS VERY…”
    +1 more passage from the same document
    • “…the ongoing extension phase of the trial and terminated the trial. In August 2025, our board of directors initiated a…”
  • 2026-06-15reverse splitrecentOpen filing ↗
    “…stock split is to increase the per-share market price of VYNE Common Stock above the minimum bid price requirement under the Nasdaq…”
    +1 more passage from the same document
    • “…Common Stock being issued in the Merger on Nasdaq will be approved. Based on the recent trading prices of VYNE Common Stock, VYNE…”
  • 2026-06-03share offering or dilution eventrecentOpen filing ↗
    “…through a combination of equity offerings, debt financings, collaborations, strategic alliances and licensing arrangements. On March…”
    +1 more passage from the same document
    • “…under 2023 Plan (Note 13) 188,100 Outstanding restricted stock units (Note 13) 450,916 Shares available for grant under the…”
  • 2026-06-03listing compliance noticerecentOpen filing ↗
    “…with the minimum bid price requirement. On March 11, 2026, VYNE received a letter (the “Extension Notice”) from Nasdaq notifying VYNE…”
    +1 more passage from the same document
    • “…additional 180 calendar days, or until September 7, 2026, to regain compliance with the minimum bid price requirement. Nasdaq’s…”

9 older entries not shown

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Mar 11, 2026).

Open the 8-K at the SEC

Reverse splits in 5 years

2 reverse splits in 5 years (1:18 on Feb 13, 2023, 1:50 on Jul 27, 2026) · 1:900 cumulative

The other times: of 226 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 177 lost more than half and 20 rose (226 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 644)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 7, 26SCHEDULE 13G ↗Passive stake · Bellevue Group AG · 10.6% · event on Sep 10, 26
  • Sep 17, 26SCHEDULE 13G ↗Passive stake · Raymond Debbane · 7.2% · event on Sep 11, 26
  • Sep 14, 268-K ↗Current report · Entered a material agreement
  • Sep 11, 26424B5 ↗Securities offering
  • Sep 11, 26424B5 ↗Securities offering
  • Sep 10, 268-K ↗Current report · Other events
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · ADAR1 Capital Management, LLC · 8.8% · event on Jun 30, 26
  • Aug 14, 26POS AM ↗Securities offering
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · venBio Global Strategic Fund V, L.P. · 10.0% · event on Jul 27, 26
  • Aug 13, 26SCHEDULE 13G/A ↗Passive stake · Zhang Xiaofan · 0.6% · amendment
  • Aug 13, 2610-Q ↗Quarterly report
  • Aug 13, 268-K/A ↗Current report · Results · Communication to the market · amendment
  • Aug 7, 26SCHEDULE 13G ↗Passive stake · JANUS HENDERSON GROUP Ltd. · 10.0% · event on Jul 31, 26
  • Aug 7, 26SCHEDULE 13G/A ↗Passive stake · Logos Global Management LP · 10.7% · event on Jul 31, 26 · amendment
  • Aug 5, 26SCHEDULE 13D ↗Stake with intent to influence · ORBIMED ADVISORS LLC · 10.0% · event on Jul 27, 26
  • Aug 4, 26SCHEDULE 13G ↗Passive stake · Logos Global Management LP · 9.9% · event on Jul 27, 26
  • Aug 3, 26SCHEDULE 13G ↗Passive stake · Perceptive Advisors LLC · 10.0% · event on Jul 27, 26
  • Jul 30, 26SCHEDULE 13G ↗Passive stake · RTW Fund Group GP, LLC · 10.0% · event on Jul 27, 26
  • Jul 30, 26Form 4 ↗Insider transaction
  • Jul 30, 268-K ↗Current report · Other events
  • Insider transaction · 2 Form 3 filingsshow all 2hide
  • Jul 29, 26SCHEDULE 13D/A ↗Stake with intent to influence · AI Biotechnology LLC · 6.0% · event on Jul 27, 26 · amendment
  • Insider transaction · 2 Form 4 filingsshow all 2hide

644 filings on record, the oldest from Nov 28, 17.

Listing the 25 most recent filings of the 644 on record.

8-Ks, explained

Stress4Structure28Governance26
  • Sep 14, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jul 28, 26StructureCompleted an acquisition or disposal+10 more in the same filing8-K 2.01 ↗
  • Mar 11, 26StressListing notice (8-K 3.01)nominal item 3.01: the filing covers another matter8-K 3.01 ↗
  • Jan 30, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Dec 17, 25StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
  • Sep 12, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Governance4 senior executive changes2023 – 2025show all 4hide
    • Aug 14, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Dec 12, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jan 3, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Dec 13, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Structure3 material agreements entered2023show all 3hide
    • Oct 30, 23StructureEntered a material agreement+7 more in the same filing8-K 1.01 ↗
    • May 1, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Feb 28, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Aug 30, 22StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Jun 17, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Apr 7, 22GovernanceAuditor change filing (8-K Item 4.01)+2 more in the same filing8-K 4.01 ↗
  • Mar 15, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

3 older filings not shown · The record reaches back to Mar 16, 18.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 4 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • ORBIMED ADVISORS LLC10.0%Jul 27, 26SCHEDULE 13D ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • AI Biotechnology LLC6.0%Jul 27, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Logos Global Management LP10.7%Jul 31, 26SCHEDULE 13G/A ↗8 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Bellevue Group AG10.6%Sep 10, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • JANUS HENDERSON GROUP Ltd.10.0%Jul 31, 26SCHEDULE 13G ↗
  • Perceptive Advisors LLC10.0%Jul 27, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • RTW Fund Group GP, LLC10.0%Jul 27, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
show 5 more holdershide
  • venBio Global Strategic Fund V, L.P.10.0%Jul 27, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • ADAR1 Capital Management, LLC8.8%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Raymond Debbane7.2%Sep 11, 26SCHEDULE 13G ↗8 co-filers on this document — the figure is the largest single stake, not their sum.
  • Nantahala Capital Management, LLC6.0%Mar 31, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Zhang Xiaofan0.6%Aug 13, 26SCHEDULE 13G/A ↗1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jan 15, 25Buy$44KPATRICK G LEPORE↗
Stock compensation, tax and giftsshow the 39 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jul 29, 26Otheramount n/aRTW Fund Group GP, LLC↗
  • Jul 23, 26Tax$14KIain StuartCHIEF SCIENTIFIC OFFICER↗
  • Jul 23, 26Tax$71KDavid DomzalskiPRESIDENT AND CEO↗
  • Jul 23, 26Tax$20KMutya HarschCHIEF LEGAL OFFICER AND GC↗
  • Jul 23, 26Tax$20KTyler ZerondaCHIEF FINANCIAL OFFICER↗
  • Jun 30, 26Tax$2KIain StuartCHIEF SCIENTIFIC OFFICER↗
  • Jun 30, 26Tax$8KDavid DomzalskiPRESIDENT AND CEO↗
  • Jun 30, 26Tax$2KMutya HarschCHIEF LEGAL OFFICER AND GC↗
  • Jun 30, 26Tax$2KTyler ZerondaCHIEF FINANCIAL OFFICER↗
  • May 29, 26Compensation$10KDavid DomzalskiPRESIDENT AND CEO↗
  • Mar 31, 26Tax$2KIain StuartCHIEF SCIENTIFIC OFFICER↗
  • Mar 31, 26Tax$9KDavid DomzalskiPRESIDENT AND CEO↗
  • Mar 31, 26Tax$2KMutya HarschCHIEF LEGAL OFFICER AND GC↗
  • Mar 31, 26Tax$2KTyler ZerondaCHIEF FINANCIAL OFFICER↗
  • Dec 31, 25Tax$1KIain StuartCHIEF SCIENTIFIC OFFICER↗
  • Dec 31, 25Tax$7KDavid DomzalskiPRESIDENT AND CEO↗
  • Dec 31, 25Tax$2KMutya HarschCHIEF LEGAL OFFICER AND GC↗
  • Dec 31, 25Tax$5KTyler ZerondaCHIEF FINANCIAL OFFICER↗
  • Sep 30, 25Tax$822Iain StuartCHIEF SCIENTIFIC OFFICER↗
  • Sep 30, 25Tax$4KDavid DomzalskiPRESIDENT AND CEO↗
  • Sep 30, 25Tax$1KMutya HarschCHIEF LEGAL OFFICER AND GC↗
  • Sep 30, 25Tax$1KTyler ZerondaCHIEF FINANCIAL OFFICER↗
  • Jun 30, 25Tax$21KDavid DomzalskiPRESIDENT AND CEO↗
  • Jun 30, 25Tax$6KMutya HarschCHIEF LEGAL OFFICER AND GC↗
  • Jun 30, 25Tax$4KIain StuartCHIEF SCIENTIFIC OFFICER↗
  • Jun 30, 25Tax$6KTyler ZerondaCHIEF FINANCIAL OFFICER↗
  • Jun 2, 25Compensation$7KDavid DomzalskiPRESIDENT AND CEO↗
  • Jun 2, 25Compensation$927Mutya HarschCHIEF LEGAL OFFICER AND GC↗
  • Mar 31, 25Tax$48KDavid DomzalskiPRESIDENT AND CEO↗
  • Mar 31, 25Tax$14KMutya HarschCHIEF LEGAL OFFICER AND GC↗
  • Mar 31, 25Tax$10KIain StuartCHIEF SCIENTIFIC OFFICER↗
  • Mar 31, 25Tax$13KTyler ZerondaCHIEF FINANCIAL OFFICER↗
  • Dec 31, 24Tax$82KDavid DomzalskiPRESIDENT AND CEO↗
  • Dec 31, 24Tax$16KMutya HarschCHIEF LEGAL OFFICER AND GC↗
  • Dec 31, 24Tax$16KIain StuartCHIEF SCIENTIFIC OFFICER↗
  • Dec 31, 24Tax$16KTyler ZerondaCHIEF FINANCIAL OFFICER↗
  • Nov 30, 24Compensation$8KDavid DomzalskiPRESIDENT AND CEO↗
  • Sep 30, 24Tax$1KDavid DomzalskiPRESIDENT AND CEO↗
  • Sep 30, 24Tax$197Mutya HarschCHIEF LEGAL OFFICER AND GC↗

The full record holds 85 transactions and goes back to Dec 31, 22.

Its sector and its market

Yarrow Bioscience, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Yarrow Bioscience, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Yarrow Bioscience, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
644 documents on file, from Nov 28, 2017 to Oct 7, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.